A 40-year-old patient with moderate to severe asthma, despite maximal therapy with inhaled corticost

A 40-year-old patient with moderate to severe asthma, despite maximal therapy with inhaled corticosteroids (ICS), presents to their pulmonologist. After discussing treatment options, the pulmonologist decides to initiate biologic therapy with Omalizumab (Xolair). Which of the following statements regarding Omalizumab is true? Group of answer choices Patients can self-administer the medication at home via intramuscular injection Patients must be observed in a healthcare facility after the first three doses Omalizumab decreases the production of interleukin-4 by mast cells It is indicated for patients with non-allergic asthma

******CLICK ORDER NOW BELOW AND OUR WRITERS WILL WRITE AN ANSWER TO THIS ASSIGNMENT OR ANY OTHER ASSIGNMENT, DISCUSSION, ESSAY, HOMEWORK OR QUESTION YOU MAY HAVE. OUR PAPERS ARE PLAGIARISM FREE*******."